SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.40    2.60 (1.70%)
Bid:
155.20
Ask:
155.60
Spread: 0.40 (0.258%)
Market Cap: £889.38m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Trading Statement

30 Apr 2019 07:00

RNS Number : 4715X
Elementis PLC
30 April 2019
 

Elementis plc

AGM Trading Statement

Market conditions remain challenging, particularly in Coatings

On track to deliver further progress in 2019 led by self-help initiatives

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 March 2019.

Reflecting broader macroeconomic trends, global market conditions remain challenging, particularly in Coatings. Elementis anticipates further progress in 2019, albeit slightly below expectations. Some improvement in the demand environment and further cost efficiencies in-train are expected to result in a stronger second half performance.

The Group remains focused on delivering its plans to integrate the Talc business, transform Coatings and grow Personal Care. This strategy, supported by self-help measures focused on cost efficiency and cash delivery will provide a robust financial platform to deliver future growth and shareholder value creation.

Business performance

· Personal Care had a solid first quarter with strong growth in cosmetics offset by a weaker start in anti-perspirant active ingredients. Bentone HydroclayTM, our new hectorite-based ingredient focused on the skin care market, launched in the quarter and is building encouraging customer momentum.

 

· In Coatings, whilst price/mix improved, weak demand and some de-stocking, particularly in Asia, caused revenue to decline versus the strong prior year period. Early benefits of the transformation programme helped to partially mitigate the profit impact and the programme continues to progress at pace.

 

· Integration of the Talc business remains on track for completion by October 2019 with a focus on delivering $2m of identified cost synergies and new business opportunities. Against strong comparatives, the business saw robust performance across most of its industrial talc applications but weaker demand from paper and automotive markets.

 

· Energy had a steady start to the year with industry infrastructure constraints in North America anticipated to ease in H2.

 

· Chromium sales grew on the prior year period with improved pricing offsetting lower demand levels.

 

Commenting on the performance, CEO, Paul Waterman said,

"Whilst trading conditions in the first quarter of 2019 have proved challenging, Elementis remains focused on delivery, improving returns and deleveraging. This will be underpinned by the integration of the Talc business, delivery of self-help efficiency measures and an unrelenting focus on cash generation."

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFFTSVIAFIA
Date   Source Headline
21st Nov 20255:47 pmRNSTransaction in Own Shares
21st Nov 20259:28 amRNSDirector/PDMR Shareholding
20th Nov 20255:34 pmRNSTransaction in Own Shares
19th Nov 20256:08 pmRNSTransaction in Own Shares
18th Nov 20255:45 pmRNSTransaction in Own Shares
17th Nov 20256:03 pmRNSTransaction in Own Shares
14th Nov 20255:31 pmRNSTransaction in Own Shares
13th Nov 20255:39 pmRNSTransaction in Own Shares
12th Nov 20255:29 pmRNSTransaction in Own Shares
11th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20255:56 pmRNSTransaction in Own Shares
7th Nov 20255:33 pmRNSTransaction in Own Shares
6th Nov 20255:34 pmRNSTransaction in Own Shares
5th Nov 20256:13 pmRNSTransaction in Own Shares
4th Nov 20255:40 pmRNSTransaction in Own Shares
3rd Nov 20255:56 pmRNSTransaction in Own Shares
31st Oct 20255:55 pmRNSTransaction in Own Shares
30th Oct 20255:36 pmRNSTransaction in Own Shares
29th Oct 20255:43 pmRNSTransaction in Own Shares
29th Oct 20257:00 amRNSThird Quarter Trading Update
28th Oct 20256:29 pmRNSTransaction in Own Shares
27th Oct 20255:28 pmRNSTransaction in Own Shares
24th Oct 20256:06 pmRNSTransaction in Own Shares
23rd Oct 20255:45 pmRNSTransaction in Own Shares
22nd Oct 20255:35 pmRNSTransaction in Own Shares
21st Oct 20255:48 pmRNSTransaction in Own Shares
20th Oct 20256:10 pmRNSTransaction in Own Shares
17th Oct 20255:31 pmRNSTransaction in Own Shares
16th Oct 20256:00 pmRNSTransaction in Own Shares
15th Oct 20256:27 pmRNSTransaction in Own Shares
15th Oct 20256:25 pmRNSCorrection - Transaction in Own Shares
14th Oct 20255:31 pmRNSTransaction in Own Shares
13th Oct 20255:29 pmRNSTransaction in Own Shares
10th Oct 20255:33 pmRNSTransaction in Own Shares
9th Oct 20255:41 pmRNSTransaction in Own Shares
8th Oct 20255:24 pmRNSTransaction in Own Shares
7th Oct 20255:26 pmRNSTransaction in Own Shares
6th Oct 20255:38 pmRNSTransaction in Own Shares
3rd Oct 20255:35 pmRNSTransaction in Own Shares
2nd Oct 20255:33 pmRNSTransaction in Own Shares
1st Oct 20255:42 pmRNSTransaction in Own Shares
30th Sep 20255:39 pmRNSTransaction in Own Shares
30th Sep 20257:00 amRNSDirectorate Change
29th Sep 20255:13 pmRNSTransaction in Own Shares
26th Sep 20255:38 pmRNSTransaction in Own Shares
25th Sep 20255:52 pmRNSTransaction in Own Shares
24th Sep 20255:42 pmRNSTransaction in Own Shares
23rd Sep 20255:22 pmRNSTransaction in Own Shares
22nd Sep 20255:37 pmRNSTransaction in Own Shares
19th Sep 20255:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.